Skip to main content
. 2020 Aug 4;38(29):3388–3397. doi: 10.1200/JCO.20.00549

FIG 3.

FIG 3.

Kaplan-Meier survival curves for (A) recurrence-free survival (RFS) and (B) overall survival (OS) among patients with p53abn endometrial cancer (EC); (C) RFS and (D) OS among patients with POLEmut EC; (E) RFS and (F) OS among patients with MMRd EC; and (G) RFS and (H) OS among patients with NSMP EC. CTRT, combined adjuvant chemotherapy and radiotherapy; HR, hazard ratio; MMRd, MMR-deficient; NSMP, no specific molecular profile; p53abn, p53-abnormal; Pcox, P value by Cox regression analysis; POLEmut, POLE-ultramutated tumor; RT, external beam radiotherapy alone.